Skip to main content
. 2019 Aug;10(4):766–776. doi: 10.21037/jgo.2019.03.07

Figure 2.

Figure 2

Kaplan Meier plots of overall survival from the day of starting the treatment using the levels of (A) IL-10, (B) miR-141, and (C) miR-21. Serum IL-10 and circulating miRNAs were used as binary variables to differentiate patients according to a cutoff value determined as the median value for IL-10 and the median value of the –ΔΔCt for miRNAs. The log-rank test was between serum IL-10 and miRNAs levels (high vs. low) with the time to survival.